The article focuses on a research related to the factors concerned with the intermittent treatment of mycobacterium avium complex (MAC) lung disease. The findings showed that adjunctive immunomodulatory therapy did not impro...
Treatment of Mycobacterium avium Complex (MAC) Pulmonary Disease BACKGROUND: There has been a gradual increase in the number of newly diagnosed cases of Mycobacterium avium complex (MAC) pulmonary disease. However, the optimal therapeutic regimen for the disease has not yet established and there is...
Treatment of pulmonary hypertension in interstitial lung disease: do not throw out the baby with the bath water 来自 国家科技图书文献中心 喜欢 0 阅读量: 15 作者: Cottin,V.摘要: Comment on Eur Respir J. 2013 Apr;41(4):853-60.关键词:...
Refractory pulmonary aspergillosis: compassionate trial with terbinafine. Br J Dermatol. 1996;134(Suppl 46):25–29. Article PubMed Google Scholar Moore CB, Walls CM, Denning DW. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin ...
Inhaled amikacin for severe Gram-negative pulmonary infections in the intensive care unit: Current status and future prospects. Crit. Care 2018, 22, 343. [Google Scholar] [CrossRef] [PubMed] [Green Version] Goldstein, I.; Wallet, F.; Robert, J.; Becquemin, M.H.; Marquette, C.H.; ...
The SEATTLE II (A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism) study enrolled 150 acute PE patients treated with ultrasound-assisted catheter-directed thrombolysis and reported an ...
OSIS AND TREATMENT. Clinical Lecture ON BASIC PULMONARY CAVITIES, THEIR DIAGNOSIS AND TREATMENT.Clinical Lecture ON BASIC PULMONARY CAVITIES, THEIR DIAGNOSIS AND TREATMENT.doi:10.1016/S0140-6736(01)88089-2MacdonaldJ.W.
关键词: Humans Tuberculosis, Pulmonary Recurrence Antitubercular Agents Treatment Outcome Drug Administration Schedule Severity of Illness Index Case-Control Studies Follow-Up Studies Dose-Response Relationship, Drug DOI: 10.1164/rccm.2409005 被引量: 23 ...
These results suggest that the pulmonary administration route for mepenzolate may be super- ior to other routes to treat COPD patients. Results Effect of different administration routes of mepenzolate on pulmo- nary damage and airway resistance. We recently reported that the intratracheal ...
Almost any organ can be affected, although the gastrointestinal, skin, endocrine and pulmonary effects predominate (Pham et al, 2015). The majority of these side effects can be managed by treatment interruption and immunosuppressive therapies when the severity warrants it (Pham et al, 2015). It ...